Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to correct three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible correction of metatarsus adductus deformities and osteoarthritis of the midfoot. It serves physicians, surgeons, ambulatory surgery centers and hospitals related to the surgical management of bunion and related midfoot deformities. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida. Show more
Location: 100 Palmetto Park Place, Ponte Vedra, FL, 32081, United States | Website: https://www.treace.com | Industry: Medical Devices | Sector: Healthcare
Market Cap
182.2M
52 Wk Range
$2.56 - $10.79
Previous Close
$2.61
Open
$2.58
Volume
1,353,237
Day Range
$2.56 - $2.92
Enterprise Value
194.9M
Cash
57.42M
Avg Qtr Burn
-3.038M
Insider Ownership
25.39%
Institutional Own.
58.60%
Qtr Updated
09/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
